Clinical Trial Update: Exploratory Study on the Treatment of Relapsed and Refractory Immune Related Diseases With WGb-0301 Injection [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 exploratory clinical trial is evaluating WGb-0301 Injection for relapsed and refractory autoimmune diseases; the study is currently not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases

Drugs mentioned

• WGb-0301 Injection

Snippet

Sponsor: West China Hospital | Conditions: Autoimmune Diseases | EARLY_Phase 1 | Status: NOT_YET_RECRUITING